Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 218 | $182,336,147 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
27 Apr 2023 16:37 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 25 Apr 2023 | Sale | 100 | 103.82 | 10,382 | D |
11 Dec 2023 18:18 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 08 Dec 2023 | Sale | 100 | 120 | 12,000 | D |
10 Nov 2022 17:50 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 10 Nov 2022 | Sale | 100 | 125.362 | 12,536 | D |
02 Feb 2023 17:26 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 31 Jan 2023 | Sale | 126 | 108.48 | 13,668 | D |
12 Mar 2024 18:47 | NBIX | NEUROCRINE BIOSCIENCES INC | POPS RICHARD F | Director | 11 Mar 2024 | Sale | 100 | 140 | 14,000 | D |
02 Feb 2024 19:26 | NBIX | NEUROCRINE BIOSCIENCES INC | ONYIA JUDE | Chief Scientific Officer | 31 Jan 2024 | Sale | 126 | 141.94 | 17,884 | D |
11 Dec 2023 18:18 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 08 Dec 2023 | Sale | 200 | 120.155 | 24,031 | D |
08 Feb 2023 19:22 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 06 Feb 2023 | Sale | 240 | 105.609 | 25,346 | D |
12 Mar 2024 18:38 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 11 Mar 2024 | Sale | 200 | 140 | 28,000 | D |
08 Feb 2024 19:46 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 06 Feb 2024 | Sale | 216 | 141.96 | 30,663 | D |
08 Feb 2024 19:46 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 06 Feb 2024 | Sale | 240 | 141.96 | 34,070 | D |
29 Feb 2024 19:02 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 29 Feb 2024 | Sale | 273 | 135.51 | 36,994 | D |
04 Jun 2024 16:23 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 31 May 2024 | Sale | 273 | 136.55 | 37,278 | D |
03 Apr 2024 16:44 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 01 Apr 2024 | Sale | 272 | 137.3 | 37,346 | D |
02 Jul 2024 21:09 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 01 Jul 2024 | Sale | 272 | 138.11 | 37,566 | D |
08 May 2024 16:26 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 06 May 2024 | Sale | 273 | 140.55 | 38,370 | D |
08 Aug 2024 17:16 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 06 Aug 2024 | Sale | 273 | 147.7 | 40,322 | D |
10 Jan 2023 17:13 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 06 Jan 2023 | Sale | 400 | 125 | 50,000 | D |
04 Nov 2022 16:56 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 02 Nov 2022 | Sale | 400 | 125 | 50,000 | D |
02 Nov 2022 18:33 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 02 Nov 2022 | Sale | 400 | 125 | 50,000 | D |
02 Feb 2024 19:14 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 31 Jan 2024 | Sale | 422 | 141.94 | 59,899 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 06 Feb 2023 | Sale | 575 | 104.28 | 59,961 | D |
18 Jul 2024 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 16 Jul 2024 | Sale | 400 | 150.1025 | 60,041 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 08 Feb 2023 | Sale | 628 | 103.69 | 65,117 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 06 Feb 2023 | Sale | 640 | 105.4659 | 67,498 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 08 Feb 2023 | Sale | 700 | 103.9514 | 72,766 | D |
08 Feb 2023 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | LLOYD-SMITH MALCOLM | Chief Integration Officer | 08 Feb 2023 | Sale | 701 | 103.8296 | 72,785 | D |
08 Feb 2023 19:22 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 08 Feb 2023 | Sale | 700 | 104.1086 | 72,876 | D |
08 Feb 2024 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 06 Feb 2024 | Sale | 575 | 141.96 | 81,627 | D |
08 Feb 2023 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | LLOYD-SMITH MALCOLM | Chief Integration Officer | 06 Feb 2023 | Sale | 801 | 105.8153 | 84,758 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 07 Feb 2023 | Sale | 822 | 104.03 | 85,513 | D |
08 Feb 2024 19:46 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 08 Feb 2024 | Sale | 628 | 136.78 | 85,898 | D |
08 Feb 2024 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 08 Feb 2024 | Sale | 629 | 136.78 | 86,035 | D |
02 Feb 2024 19:14 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 01 Feb 2024 | Sale | 623 | 139.77 | 87,077 | D |
08 Feb 2024 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 06 Feb 2024 | Sale | 640 | 142.1715 | 90,990 | D |
06 Sep 2023 16:22 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 01 Sep 2023 | Sale | 824 | 110.93 | 91,406 | D |
08 Feb 2023 19:56 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 07 Feb 2023 | Sale | 913 | 102.2457 | 93,350 | D |
08 Feb 2024 19:46 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 08 Feb 2024 | Sale | 700 | 134.189 | 93,932 | D |
08 Feb 2024 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 08 Feb 2024 | Sale | 700 | 134.2298 | 93,961 | D |
08 Feb 2023 19:32 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 08 Feb 2023 | Sale | 911 | 104.0779 | 94,815 | D |
21 Apr 2023 18:58 | NBIX | NEUROCRINE BIOSCIENCES INC | RASTETTER WILLIAM H | Director | 19 Apr 2023 | Sale | 903 | 105.004 | 94,819 | D |
15 Feb 2024 17:38 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 13 Feb 2024 | Sale | 716 | 133.0346 | 95,253 | D |
02 Feb 2023 17:07 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 31 Jan 2023 | Sale | 916 | 108.48 | 99,368 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 08 Feb 2023 | Sale | 980 | 103.9898 | 101,910 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 08 Feb 2023 | Sale | 980 | 104.1184 | 102,036 | D |
08 Feb 2023 19:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 08 Feb 2023 | Sale | 980 | 104.1551 | 102,072 | D |
08 Feb 2023 19:16 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 08 Feb 2023 | Sale | 980 | 104.1939 | 102,110 | D |
08 Feb 2023 19:35 | NBIX | NEUROCRINE BIOSCIENCES INC | LLOYD-SMITH MALCOLM | Chief Integration Officer | 07 Feb 2023 | Sale | 1,015 | 102.1609 | 103,693 | D |
15 Feb 2024 17:35 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 13 Feb 2024 | Sale | 796 | 133.0429 | 105,902 | D |
08 Feb 2023 19:32 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 06 Feb 2023 | Sale | 1,041 | 105.8035 | 110,141 | D |
15 Feb 2024 17:33 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 13 Feb 2024 | Sale | 856 | 133.0484 | 113,889 | D |
02 Feb 2024 19:11 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 31 Jan 2024 | Sale | 824 | 141.94 | 116,959 | D |
08 Feb 2023 19:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 06 Feb 2023 | Sale | 1,121 | 105.8004 | 118,602 | D |
02 Feb 2023 17:04 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 31 Jan 2023 | Sale | 1,104 | 109.9172 | 121,349 | D |
08 Feb 2024 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 08 Feb 2024 | Sale | 911 | 134.2359 | 122,289 | D |
15 Feb 2024 17:33 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 13 Feb 2024 | Sale | 955 | 133.0956 | 127,106 | D |
02 Feb 2024 19:11 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 31 Jan 2024 | Sale | 916 | 140.7019 | 128,883 | D |
08 Feb 2024 19:15 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 08 Feb 2024 | Sale | 980 | 134.1925 | 131,509 | D |
08 Feb 2024 19:17 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 08 Feb 2024 | Sale | 980 | 134.2032 | 131,519 | D |
08 Feb 2024 19:28 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 08 Feb 2024 | Sale | 980 | 134.2061 | 131,522 | D |
08 Feb 2024 19:12 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 08 Feb 2024 | Sale | 980 | 134.2135 | 131,529 | D |
02 Feb 2023 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 31 Jan 2023 | Sale | 1,207 | 109.9505 | 132,710 | D |
18 Jul 2024 17:12 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 16 Jul 2024 | Sale | 900 | 150.04 | 135,036 | D |
18 Jul 2024 17:00 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 16 Jul 2024 | Sale | 900 | 150.04 | 135,036 | D |
18 Jul 2024 16:45 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 16 Jul 2024 | Sale | 900 | 150.0411 | 135,037 | D |
08 Feb 2023 19:18 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 06 Feb 2023 | Sale | 1,280 | 105.6256 | 135,201 | D |
08 Feb 2023 19:16 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 06 Feb 2023 | Sale | 1,280 | 105.6667 | 135,253 | D |
02 Feb 2023 17:21 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 31 Jan 2023 | Sale | 1,250 | 109.9712 | 137,464 | D |
01 Sep 2023 16:36 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 30 Aug 2023 | Sale | 1,295 | 106.9 | 138,436 | D |
18 Jul 2024 16:54 | NBIX | NEUROCRINE BIOSCIENCES INC | LYONS GARY A | Director | 16 Jul 2024 | Sale | 930 | 150.0325 | 139,530 | D |
02 Feb 2024 19:07 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 31 Jan 2024 | Sale | 992 | 140.7172 | 139,591 | D |
02 Feb 2023 16:53 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 31 Jan 2023 | Sale | 1,283 | 109.9827 | 141,108 | D |
04 Nov 2022 17:02 | NBIX | NEUROCRINE BIOSCIENCES INC | COOKE JULIE | Chief Human Resources Officer | 02 Nov 2022 | Sale | 1,144 | 124.9675 | 142,963 | D |
15 Feb 2024 17:45 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 13 Feb 2024 | Sale | 1,098 | 132.9949 | 146,028 | D |
15 Feb 2024 17:29 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 13 Feb 2024 | Sale | 1,098 | 133.0149 | 146,050 | D |
02 Nov 2022 18:28 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 31 Oct 2022 | Sale | 1,295 | 114.12 | 147,785 | D |
08 Feb 2024 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 06 Feb 2024 | Sale | 1,041 | 142.1663 | 147,995 | D |
15 Feb 2024 17:51 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 13 Feb 2024 | Sale | 1,114 | 132.9639 | 148,122 | D |
23 Aug 2023 20:04 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 21 Aug 2023 | Sale | 1,404 | 107.4219 | 150,820 | D |
05 Oct 2022 19:07 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 03 Oct 2022 | Sale | 1,437 | 106.59 | 153,170 | D |
30 Aug 2023 16:38 | NBIX | NEUROCRINE BIOSCIENCES INC | DELAET INGRID | Chief Regulatory Officer | 28 Aug 2023 | Sale | 1,431 | 107.52 | 153,861 | D |
02 Feb 2024 19:07 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 31 Jan 2024 | Sale | 1,104 | 140.8729 | 155,524 | D |
08 Feb 2023 19:32 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 07 Feb 2023 | Sale | 1,522 | 102.2427 | 155,613 | D |
01 Sep 2023 16:36 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 30 Aug 2023 | Sale | 1,438 | 108.2218 | 155,623 | D |
21 May 2024 17:06 | NBIX | NEUROCRINE BIOSCIENCES INC | NORWALK LESLIE V | Director | 17 May 2024 | Sale | 1,106 | 141.8173 | 156,850 | D |
21 May 2024 17:35 | NBIX | NEUROCRINE BIOSCIENCES INC | SHARP SHALINI | Director | 17 May 2024 | Sale | 1,106 | 141.9018 | 156,943 | D |
08 Feb 2024 19:28 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 06 Feb 2024 | Sale | 1,121 | 142.2356 | 159,446 | D |
02 Feb 2023 17:28 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 31 Jan 2023 | Sale | 1,457 | 109.9887 | 160,254 | D |
04 Oct 2023 17:07 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 02 Oct 2023 | Sale | 1,437 | 112.68 | 161,921 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 07 Feb 2023 | Sale | 1,623 | 102.2884 | 166,014 | D |
08 Feb 2023 19:40 | NBIX | NEUROCRINE BIOSCIENCES INC | ROBERTS EIRY | Chief Medical Officer | 07 Feb 2023 | Sale | 1,623 | 102.35 | 166,114 | D |
08 Feb 2023 19:25 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 06 Feb 2023 | Sale | 1,600 | 105.6422 | 169,028 | D |
02 Feb 2023 17:15 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 31 Jan 2023 | Sale | 1,541 | 109.9847 | 169,486 | D |
02 Feb 2024 19:05 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 31 Jan 2024 | Sale | 1,207 | 140.7844 | 169,927 | D |
23 Aug 2023 19:59 | NBIX | NEUROCRINE BIOSCIENCES INC | BENEVICH ERIC | Chief Commercial Officer | 21 Aug 2023 | Sale | 1,600 | 107.3975 | 171,836 | D |
23 Aug 2023 20:01 | NBIX | NEUROCRINE BIOSCIENCES INC | BOYER DAVID W. | Chief Corp. Affairs Officer | 21 Aug 2023 | Sale | 1,600 | 107.4138 | 171,862 | D |
02 Feb 2024 19:24 | NBIX | NEUROCRINE BIOSCIENCES INC | LIPPOLDT DARIN | Chief Legal Officer | 31 Jan 2024 | Sale | 1,250 | 140.6478 | 175,810 | D |
15 Feb 2024 17:27 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 13 Feb 2024 | Sale | 1,352 | 132.8488 | 179,612 | D |
15 Feb 2024 17:40 | NBIX | NEUROCRINE BIOSCIENCES INC | GANO KYLE | Chief Business Development Off | 13 Feb 2024 | Sale | 1,352 | 132.8947 | 179,674 | D |
02 Feb 2024 19:00 | NBIX | NEUROCRINE BIOSCIENCES INC | ABERNETHY MATT | Chief Financial Officer | 31 Jan 2024 | Sale | 1,283 | 140.7161 | 180,539 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)